The Wnt/β-catenin signaling pathway regulates the development of airway remodeling in patients with asthma

Experimental and Molecular Medicine

Volumn 47, Issue 12, 2015, Pages

  Kwak, Hyun Jung ^a   Park, Dong Won ^a   Seo, Ji Young ^a   Moon, Ji Yong ^a   Kim, Tae Hyung ^a   Sohn, Jang Won ^a   Shin, Dong Ho ^a   Yoon, Ho Joo ^a   Park, Sung Soo ^a   Kim, Sang Heon ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MESSENGER RNA; SMALL INTERFERING RNA; WNT PROTEIN; WNT7A PROTEIN, HUMAN;

ADULT; AGED; AIRWAY REMODELING; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; CHRONIC DISEASE; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RNA INTERFERENCE; WNT SIGNALING PATHWAY;

ADULT; AGED; AIRWAY REMODELING; ANIMALS; ASTHMA; BETA CATENIN; CHRONIC DISEASE; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; LUNG; MALE; MICE, INBRED BALB C; MIDDLE AGED; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 85006307443     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/EMM.2015.91     Document Type: Article

References (41)

1. Reddel HK, Bateman ED, Becker A, Boulet LP, Cruz AA, Drazen JM et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J 2015; 46: 622–639.
2. Jarjour NN, Erzurum SC, Bleecker ER, Calhoun WJ, Castro M, Comhair SA et al. Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. Am J Respir Crit Care Med 2012; 185: 356–362.
3. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. NEnglJMed1998; 339: 1194–1200.
4. Witt CA, Sheshadri A, Carlstrom L, Tarsi J, Kozlowski J, Wilson B et al. Longitudinal changes in airway remodeling and air trapping in severe asthma. Acad Radiol 2014; 21: 986–993.
5. Al-Muhsen S, Johnson JR, Hamid Q. Remodeling in asthma. JAllergyClin Immunol 2011; 128: 451–462.
6. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001; 164: 744–748.
7. Berair R, Brightling CE. Asthma therapy and its effect on airway remodelling. Drugs 2014; 74: 1345–1369.
8. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009; 17: 9–26.
9. Macdonald BT, Semenov MV, He X. SnapShot: Wnt/beta-catenin signaling. Cell 2007; 131: 1204.
10. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012; 149: 1192–1205.
11. George SJ. Wnt pathway: a new role in regulation of inflammation. Arterioscler Thromb Vasc Biol 2008; 28: 400–402.
12. Pongracz JE, Stockley RA. Wnt signalling in lung development and diseases. Respir Res 2006; 7: 15.
13. Van Scoyk M, Randall J, Sergew A, Williams LM, Tennis M, Winn RA. Wnt signaling pathway and lung disease. Transl Res 2008; 151: 175–180.
14. Konigshoff M, Eickelberg O. WNT. signaling in lung disease: a failure or a regeneration signal? Am J Respir Cell Mol Biol 2010; 42: 21–31.
15. Guo Y, Xiao L, Sun L, Liu F. Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res 2012; 61: 337–346.
16. Liu L, Carron B, Yee HT, Yie TA, Hajjou M, Rom W. Wnt pathway in pulmonary fibrosis in the bleomycin mouse model. J Environ Pathol Toxicol Oncol 2009; 28: 99–108.
17. Chilosi M, Poletti V, Zamo A, Lestani M, Montagna L, Piccoli P et al. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 2003; 162: 1495–1502.
18. Kim TH, Kim SH, Seo JY, Chung H, Kwak HJ, Lee SK et al. Blockade of the Wnt/beta-catenin pathway attenuates bleomycin-induced pulmonary fibrosis. Tohoku J Exp Med 2011; 223: 45–54.
19. Henderson WR Jr., Chi EY, Ye X, Nguyen C, Tien YT, Zhou B et al. Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci USA 2010; 107: 14309–14314.
20. de Jesus Perez V, Yuan K, Alastalo TP, Spiekerkoetter E, Rabinovitch M. Targeting the Wnt signaling pathways in pulmonary arterial hypertension. Drug Discov Today 2014; 19: 1270–1276.
21. Fishman P, Madi L, Bar-Yehuda S, Barer F, Del Valle L, Khalili K. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells. Oncogene 2002; 21: 4060–4064.
22. Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. AmJRespirCritCareMed2009; 180: 388–395.
23. Syed F, Huang CC, Li K, Liu V, Shang T, Amegadzie BY et al. Identification of interleukin-13 related biomarkers using peripheral blood mononuclear cells. Biomarkers 2007; 12: 414–423.
24. Choy DF, Modrek B, Abbas AR, Kummerfeld S, Clark HF, Wu LC et al. Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways. JImmunol2011; 186: 1861–1869.
25. Sharma S, Tantisira K, Carey V, Murphy AJ, Lasky-Su J, Celedon JC et al. A role for Wnt signaling genes in the pathogenesis of impaired lung function in asthma. Am J Respir Crit Care Med 2010; 181: 328–336.
26. Wang SH, Xu F, Dang HX, Yang L. Genetic variations in the Wnt signaling pathway affect lung function in asthma patients. Genet Mol Res 2013; 12: 1829–1833.
27. Kim TH, Moon JY, Kim SH, Paik SS, Yoon HJ, Shin DH et al. Clinical significance of aberrant Wnt7a promoter methylation in human non-small cell lung cancer in Koreans. J Korean Med Sci 2015; 30: 155–161.
28. Rai PR, Cool CD, King JA, Stevens T, Burns N, Winn RA et al. The cancer paradigm of severe pulmonary arterial hypertension. Am J Respir Crit Care Med 2008; 178: 558–564.
29. Lezmi G, Gosset P, Deschildre A, Abou-Taam R, Mahut B, Beydon N et al. Airway remodeling in preschool children with severe recurrent wheeze. Am J Respir Crit Care Med 2015; 192: 164–171.
30. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1: 520–524.
31. Enzo MV, Rastrelli M, Rossi CR, Hladnik U, Segat D. The Wnt/beta-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target. Mol Cell Ther 2015; 3: 1.
32. Lam AP, Gottardi CJ. beta-catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol 2011; 23: 562–567.
33. Carre AL, James AW, MacLeod L, Kong W, Kawai K, Longaker MT et al. Interaction of wingless protein (Wnt), transforming growth factor-beta1, and hyaluronan production in fetal and postnatal fibroblasts. Plast Reconstr Surg 2010; 125: 74–88.
34. Cheon SS, Wei Q, Gurung A, Youn A, Bright T, Poon R et al. Beta-catenin regulates wound size and mediates the effect of TGF-beta in cutaneous healing. Faseb j 2006; 20: 692–701.
35. Noble PB, Pascoe CD, Lan B, Ito S, Kistemaker LE, Tatler AL et al. Airway smooth muscle in asthma: linking contraction and mechanotransduction to disease pathogenesis and remodelling. Pulm Pharmacol Ther 2014; 29: 96–107.
36. Prakash YS. Airway smooth muscle in airway reactivity and remodeling: what have we learned? Am J Physiol Lung Cell Mol Physiol 2013; 305: L912–L933.
37. Berair R, Saunders R, Brightling CE. Origins of increased airway smooth muscle mass in asthma. BMC Med 2013; 11: 145.
38. Bara I, Ozier A, Tunon de Lara JM, Marthan R, Berger P. Pathophysiology of bronchial smooth muscle remodelling in asthma. Eur Respir J 2010; 36: 1174–1184.
39. Hirst SJ, Barnes PJ, Twort CH. PDGF isoform-induced proliferation and receptor expression in human cultured airway smooth muscle cells. Am J Physiol 1996; 270: L415–L428.
40. Ito I, Fixman ED, Asai K, Yoshida M, Gounni AS, Martin JG et al. Plateletderived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells. Clin Exp Allergy 2009; 39: 1370–1380.
41. Cohen ED, Ihida-Stansbury K, Lu MM, Panettieri RA, Jones PL, Morrisey EE. Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway. JClinInvest2009; 119: 2538–2549.